Figure 5
From: Bioinformatics analysis of prognostic value and immunological role of MeCP2 in pan-cancer
DNA methylation and Phosphorylation analysis of MeCP2protein in several tumors via UALCAN database. (A) DNA Promoter methylation level of MeCP2 in BLAC, BRCA, LIHC, PRAD, TGCT and UCEC. (B) The schematic diagram of MeCP2 protein phosphoprotein sites. (C) The phosphorylation of MeCP2 protein was analyzed in BRCA, OV, KIRC, COAD, UCEC, and LUAD. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns:no significance.
